978 related articles for article (PubMed ID: 17894887)
41. Regulatory mechanisms and clinical perspectives of miR-34a in cancer.
Li L
J Cancer Res Ther; 2014; 10(4):805-10. PubMed ID: 25579512
[TBL] [Abstract][Full Text] [Related]
42. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma.
Wu W; Lin Z; Zhuang Z; Liang X
Eur J Cancer Prev; 2009 Feb; 18(1):50-5. PubMed ID: 19077565
[TBL] [Abstract][Full Text] [Related]
43. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors.
Akao Y; Nakagawa Y; Hirata I; Iio A; Itoh T; Kojima K; Nakashima R; Kitade Y; Naoe T
Cancer Gene Ther; 2010 Jun; 17(6):398-408. PubMed ID: 20094072
[TBL] [Abstract][Full Text] [Related]
44. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
Bandi N; Zbinden S; Gugger M; Arnold M; Kocher V; Hasan L; Kappeler A; Brunner T; Vassella E
Cancer Res; 2009 Jul; 69(13):5553-9. PubMed ID: 19549910
[TBL] [Abstract][Full Text] [Related]
45. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.
Leivonen SK; Mäkelä R; Ostling P; Kohonen P; Haapa-Paananen S; Kleivi K; Enerly E; Aakula A; Hellström K; Sahlberg N; Kristensen VN; Børresen-Dale AL; Saviranta P; Perälä M; Kallioniemi O
Oncogene; 2009 Nov; 28(44):3926-36. PubMed ID: 19684618
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
Lee KH; Goan YG; Hsiao M; Lee CH; Jian SH; Lin JT; Chen YL; Lu PJ
Exp Cell Res; 2009 Sep; 315(15):2529-38. PubMed ID: 19501585
[TBL] [Abstract][Full Text] [Related]
47. Anti-oncomir suppression of tumor phenotypes.
Goga A; Benz C
Mol Interv; 2007 Aug; 7(4):199-202, 180. PubMed ID: 17827440
[TBL] [Abstract][Full Text] [Related]
48. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities.
Bonci D; Coppola V; Musumeci M; Addario A; Giuffrida R; Memeo L; D'Urso L; Pagliuca A; Biffoni M; Labbaye C; Bartucci M; Muto G; Peschle C; De Maria R
Nat Med; 2008 Nov; 14(11):1271-7. PubMed ID: 18931683
[TBL] [Abstract][Full Text] [Related]
49. miRNA: the new gene silencer.
Ross JS; Carlson JA; Brock G
Am J Clin Pathol; 2007 Nov; 128(5):830-6. PubMed ID: 17951207
[TBL] [Abstract][Full Text] [Related]
50. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer.
Oh HK; Tan AL; Das K; Ooi CH; Deng NT; Tan IB; Beillard E; Lee J; Ramnarayanan K; Rha SY; Palanisamy N; Voorhoeve PM; Tan P
Clin Cancer Res; 2011 May; 17(9):2657-67. PubMed ID: 21415212
[TBL] [Abstract][Full Text] [Related]
51. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
Gandellini P; Folini M; Longoni N; Pennati M; Binda M; Colecchia M; Salvioni R; Supino R; Moretti R; Limonta P; Valdagni R; Daidone MG; Zaffaroni N
Cancer Res; 2009 Mar; 69(6):2287-95. PubMed ID: 19244118
[TBL] [Abstract][Full Text] [Related]
52. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
Babashah S; Soleimani M
Eur J Cancer; 2011 May; 47(8):1127-37. PubMed ID: 21402473
[TBL] [Abstract][Full Text] [Related]
53. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.
Voorhoeve PM; le Sage C; Schrier M; Gillis AJ; Stoop H; Nagel R; Liu YP; van Duijse J; Drost J; Griekspoor A; Zlotorynski E; Yabuta N; De Vita G; Nojima H; Looijenga LH; Agami R
Cell; 2006 Mar; 124(6):1169-81. PubMed ID: 16564011
[TBL] [Abstract][Full Text] [Related]
54. RNAi, microRNAs, and human disease.
Hammond SM
Cancer Chemother Pharmacol; 2006 Nov; 58 Suppl 1():s63-8. PubMed ID: 17093929
[TBL] [Abstract][Full Text] [Related]
55. The miR-34 family in cancer and apoptosis.
Hermeking H
Cell Death Differ; 2010 Feb; 17(2):193-9. PubMed ID: 19461653
[TBL] [Abstract][Full Text] [Related]
56. miRNAs as molecular biomarkers of cancer.
Fabbri M
Expert Rev Mol Diagn; 2010 May; 10(4):435-44. PubMed ID: 20465498
[TBL] [Abstract][Full Text] [Related]
57. MicroRNAs in tumorigenesis: a primer.
Zhang W; Dahlberg JE; Tam W
Am J Pathol; 2007 Sep; 171(3):728-38. PubMed ID: 17724137
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-modulated autophagic signaling networks in cancer.
Fu LL; Wen X; Bao JK; Liu B
Int J Biochem Cell Biol; 2012 May; 44(5):733-6. PubMed ID: 22342941
[TBL] [Abstract][Full Text] [Related]
59. [RNA interference (RNAi) and its therapeutic potential in cancer].
Vázquez-Vega S; Contreras-Paredes A; Lizano-Soberón M; Amador-Molina A; García-Carrancá A; Sánchez-Suárez LP; Benítez-Bribiesca L
Rev Invest Clin; 2010; 62(1):81-90. PubMed ID: 20415062
[TBL] [Abstract][Full Text] [Related]
60. MicroRNAs as oncogenes.
Hammond SM
Curr Opin Genet Dev; 2006 Feb; 16(1):4-9. PubMed ID: 16361094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
